Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GETGOAL-MONO: Lixisenatide Monotherapy in Type 2 Diabetes
NCT00688701Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2008
- Primary completion
- Dec 2009
- Modality
- Peptides
- Countries
- 12
01
Overview
A Phase 3 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started May 2008; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00688701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00688701.